KR830007489A - 비스-아미노메틸- 안트라퀴논 유도체의 제조방법 - Google Patents

비스-아미노메틸- 안트라퀴논 유도체의 제조방법 Download PDF

Info

Publication number
KR830007489A
KR830007489A KR1019810004526A KR810004526A KR830007489A KR 830007489 A KR830007489 A KR 830007489A KR 1019810004526 A KR1019810004526 A KR 1019810004526A KR 810004526 A KR810004526 A KR 810004526A KR 830007489 A KR830007489 A KR 830007489A
Authority
KR
South Korea
Prior art keywords
anthraquinone
formula
salt
derivative
group
Prior art date
Application number
KR1019810004526A
Other languages
English (en)
Inventor
빈켈만 에르하르트
라에테르 볼프강
롤리 헤인리흐
Original Assignee
하인리히 벡커, 베른하르트벡
훽스트 아크티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하인리히 벡커, 베른하르트벡, 훽스트 아크티엔 게젤샤프트 filed Critical 하인리히 벡커, 베른하르트벡
Publication of KR830007489A publication Critical patent/KR830007489A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/24—Quinones containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/34—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C07D295/116—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings with the doubly bound oxygen or sulfur atoms directly attached to a carbocyclic ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

내용 없음

Description

비스―아미노메틸―안트라퀴논 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. a) 일반식(Ⅱ)의 치환된 디메틸―안트라퀴논을 일반식(Ⅲ)의 아민과 반응시키고,필요시 생리적으로 무독한 산을가하여 생성물을 염으로 전환시키거나
    b) R3가 수소인 일반식(Ⅳ)의 안트라퀴논―디카복실산 아미드를 환원시키고 중간물질 안트라하이드로퀴논 유도체를 일반식(Ⅰ)의 안트라퀴논 유도체로 산화시키고, 필요시 생리적으로 무독한 산을 가하여 생성물을 염으로 전환시키거나
    c) 일반식(Ⅴ)의 안트라퀴논을 안트라하이드로퀴논으로 환원시킨 후, 이어서 분리하지 않고서 포름알데히드 및 일반식(Ⅲ)의 아민과 반응시키고 중간물질 비스―아미노메틸―안트라하이드로퀴논 유도체를 산화시키고 일반식(Ⅰ)의 안트라퀴논 유도체로, 필요시 생리적으로 무독한 산을 가하여 염으로 전환시켜서 일반식(Ⅰ)의 비스―아미노메틸―안트라퀴논 유도체 및 그의 염을 제조하는 방법.
    상기 식에서
    R1및 R2는 같거나 서로 다르며, 수소, 탄소수 1 내지 4의 직쇄 또는 측쇄알킬(예를들면 메틸, 에틸프로필, 이소프로필, 부틸 및 이소부틸)이거나
    R1및 R2는 탄소수 4,5 또는 6의 알킬렌쇄이고 질소원자와 함께 질소, 산소 및 황으로 구성된 그룹으로 부터 헤테로원자를 더 함유할 수 있는 5,6 또는 7원의 헤테로사이클환을 형성하며,
    R3는 수소 또는 하이드록실그룹이고,
    Y는 염소, 브롬 또는 요오드와 같은 할로겐원자, 아실옥시그룹 또는 아릴설포닐옥시그룹, 특히 페닐설포닐옥시그룹이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019810004526A 1980-11-24 1981-11-23 비스-아미노메틸- 안트라퀴논 유도체의 제조방법 KR830007489A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3044072.3 1980-11-24
DE19803044072 DE3044072A1 (de) 1980-11-24 1980-11-24 Bis-aminomehtyl-anthrachinon-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung

Publications (1)

Publication Number Publication Date
KR830007489A true KR830007489A (ko) 1983-10-21

Family

ID=6117355

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810004526A KR830007489A (ko) 1980-11-24 1981-11-23 비스-아미노메틸- 안트라퀴논 유도체의 제조방법

Country Status (4)

Country Link
JP (1) JPS57118540A (ko)
KR (1) KR830007489A (ko)
DE (1) DE3044072A1 (ko)
ZA (1) ZA818107B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8129519B2 (en) * 2007-05-10 2012-03-06 Cholody Wieslaw M Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
EP3248230B1 (de) * 2015-01-20 2020-05-06 cynora GmbH Verwendung organischer moleküle in optoelektronischen bauelementen

Also Published As

Publication number Publication date
DE3044072A1 (de) 1982-07-15
JPS57118540A (en) 1982-07-23
ZA818107B (en) 1982-10-27

Similar Documents

Publication Publication Date Title
KR850002459A (ko) 디히드록시벤즈아미드 유도체 및 그 제조방법
KR870008830A (ko) 질산염 유도체의 제조 방법
KR830010106A (ko) 피페라진 유도체의 제조방법
KR830007489A (ko) 비스-아미노메틸- 안트라퀴논 유도체의 제조방법
KR870007127A (ko) 퀴놀론 카복실산 유도체의 제조방법
KR830007484A (ko) 신규 신나모일-신나민산 유도체의 제조방법
KR830006302A (ko) 신규 피리미딘 유도체의 제조방법
KR830005191A (ko) 푸란유도체의 제조방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR850005441A (ko) 3-알콕시-2-(n-피롤리디노)-n-피리딜-n-푸릴메틸(또는 푸릴티에닐)-프로필아민의 제조방법
KR840009099A (ko) 사이클릭 디티오디아세트아미드의 제조방법
KR910011845A (ko) 2-푸릴피리미딘 유도체의 제조방법
KR840004404A (ko) 3-페닐피롤 유도체의 제조방법
KR840000504A (ko) N- 페닐피라졸 유도체의 제조방법
KR870002118A (ko) 벤질아민 유도체 및 그 제조방법
KR840004727A (ko) 설피닐-및 설포닐-아자 사이클로헵탄-2-온의 제조방법
KR860006461A (ko) 항알레르기 작용을 갖는 화합물의 제조방법
KR840004105A (ko) N,n- 치환된 아졸 카복스 아미드 유도체의 제조방법
KR900012924A (ko) 피리돈 카르복시산 유도체의 제조방법
KR910000712A (ko) 이미다졸 유도체의 제조방법
KR830006254A (ko) N-치환 아닐린 유도체의 제조공정
KR880006185A (ko) 신규 α-클로로케톤 유도체 및 그 제조법
KR840001150A (ko) 치환페닐(티오노)카바메이트의 제조방법
KR900018060A (ko) 피페리딜 벤즈 아미드 유도체의 제조방법
KR910009683A (ko) 티아졸 화합물의 제조방법